Antigen-antibody reactions
Antigen-antibody interaction, or antigen-antibody reaction, is a specific chemical interaction between antibodies produced by B cells of the white blood cells and antigens during immune reaction. The antigens and antibodies combine by a process called agglutination. It is the fundamental reaction in the body by which the body is protected from complex foreign molecules, such as pathogens and their chemical toxins. In the blood, the antigens are specifically and with high affinity bound by antibodies to form an antigen-antibody complex. The immune complex is then transported to cellular systems where it can be destroyed or deactivated.
Coronavirus Conference | Covid-19 Pandemic | Latest invention and Researches on Covid-19 | World Infectious Diseases 2021
- exogenous
- endogenous
- autoantigens
Related Conference of Antigen-antibody reactions
Antigen-antibody reactions Conference Speakers
Recommended Sessions
- Bacterial Infectious Diseases
- Blood and Hematology
- Blood transfusion
- Corona Virus Diseases
- Diagnosis, Treatment and Management of Blood disorders
- Hematology and neurological disorders
- Mycobacterial infections
- Pathogenic infections
- Respiratory infectious diseases
- Animal vaccination
- Antigen-antibody reactions
- Aspects of plant bacteriology
- Biomarkers in Hematology
- Blood disorders
- Chickenpox
- Diagnosis and treatment
- Effect of Advanced Technologies on Blood Based Products
- Epidemiology
- Food infections
- Hematologic Therapies
- Lower respiratory tract infection
- New Drug Discovery in Hematology
- Reproductive infectious diseases
- Sexually transmitted diseases
- Tuberculosis
Related Journals
Are you interested in
- Bleeding Disorders in Women - Blood Disorders 2024 (Ireland)
- Digital Health and Artificial Intelligence (AI) in Hematology - Blood Disorders 2024 (Ireland)
- Hematologic Gene Editing and Gene Therapies - Blood Disorders 2024 (Ireland)
- Hematology and Stem Cell Research - Blood Disorders 2024 (Ireland)
- Hematopoietic Stem Cell Transplantation - Blood Disorders 2024 (Ireland)
- Hemoglobinopathies and Sickle Cell Disease - Blood Disorders 2024 (Ireland)
- Hemophilia Management and Research - Blood Disorders 2024 (Ireland)
- Hemostasis and Thrombosis - Blood Disorders 2024 (Ireland)
- Immunotherapy and Hematology - Blood Disorders 2024 (Ireland)
- Leukemia and Lymphoma - Blood Disorders 2024 (Ireland)
- Medicine in Hematology - Blood Disorders 2024 (Ireland)
- Molecular Hematology - Blood Disorders 2024 (Ireland)
- Myelodysplastic Syndromes (MDS) and Bone Marrow Failure - Blood Disorders 2024 (Ireland)
- Next-Generation Diagnostics and Imaging - Blood Disorders 2024 (Ireland)
- Novel Therapies for Blood Cancers - Blood Disorders 2024 (Ireland)
- Pediatric Hematology - Blood Disorders 2024 (Ireland)
- Platelet Disorders - Blood Disorders 2024 (Ireland)
- Sickle Cell Disease (SCD) - Blood Disorders 2024 (Ireland)
- Thalassemia Management - Blood Disorders 2024 (Ireland)
- Transfusion Medicine and Blood Banking - Blood Disorders 2024 (Ireland)